Why This Pot Stock Could Triple!

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) may have seen its share price peak, but this other pot stock could still have a lot of room to rise.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Pot stocks have been struggling in recent months. Scandals and poor earnings are some of the big factors behind a lot of bearishness in the industry these days. However, that doesn’t mean all pot stocks are bad buys. The good news for opportunistic investors is that the sell-offs we’ve seen in the industry have created some great buying opportunities for stocks that have simply been collateral damage.

A company like Aurora Cannabis (TSX:ACB)(NYSE:ACB) is an example of a stock that hasn’t been involved in any scandal, and yet its price has tanked 30% over the past three months. However, with a market cap of more than $8 billion, it still comes at a hefty valuation. We’re seeing investors start to value cannabis stocks more conservatively, and Aurora stock may still need to come down significantly before it starts looking like a good buy.

And therein lies the problem: as well as Aurora may perform here on out, its upside may be limited. The odds that Aurora will be able to double in value are remote, unless there is a major development that happens that makes profitability more certain. With many up-and-coming U.S. pot stocks starting to attract more and more investors, it isn’t going to get any easier for Aurora to generate excitement around its stock.

One company that might have a lot more potential, however, is Auxly Cannabis Group (TSXV:XLY). The stock recently shot up more than 20% on news that it had received an investment from Imperial Brands for $123 million. The company will be purchasing convertible debt that could give it a 19.9% stake in Auxly. One of the big advantages for Auxly is that it would gain access to Imperial’s vaping technology to help grow that part of its business.

Deal could position Auxly for significant growth in the edibles segment

The timing comes of the deal comes with the edibles market just months away from becoming legal in Canada and certainly gives Auxly a big advantage with a key partner now in place.

The company’s President Hugo Alves sees the new partnership as one that could help speed up Auxly’s growth plans: “This investment from Imperial Brands will enhance Auxly’s ability to continue to deliver on our business plans and accelerate our growth initiatives to expand our portfolio of branded derivative products.”

Although Auxly has not generated much in the way of revenue over the years, that could certainly change once the edibles market gets going and especially with the company being able to take advantage of Imperial’s vaping technology. Vaping has been rising in popularity and it’s been big business south of the border, where it’s helped provide a lot of growth for the cannabis industry.

Once Auxly can start showing some strong sales growth, it might not take long for the stock to take off. The stock finished last week at just $0.90, and with a market cap of around $530 million, there’s a lot of room for it to rise in value. Doubling, even tripling in value is certainly not out of the question, now that it has a key partner that can help the company grow its business much more quickly.

Should you invest $1,000 in Canopy Growth right now?

Before you buy stock in Canopy Growth, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Canopy Growth wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »